ImmunoGen licenses technology to Amgen for $1M AP (November 19, 2009) WALTHAM, Mass. (AP) - ImmunoGen Inc. said Thursday that Amgen Inc. licensed rights to a second potential cancer-treatment from the company for $1 million upfront.
ND AG says law kept hospital merger review brief AP (November 02, 2009) BISMARCK, N.D. (AP) - Attorney General Wayne Stenehjem says North Dakota law limited his review of a merger of two large health care companies.